X Lou1, N Ma, L Ma, W-J Jiang. 1. Department of Radiology, People's Liberation Army General Hospital, Beijing, China.
Abstract
BACKGROUND AND PURPOSE: Contrast-enhanced 3T high-resolution MR imaging can be used to determine the wall enhancement pattern of the basilar artery in symptomatic atherosclerotic stenosis. We used this method to explore the relationship between wall enhancement and both recent infarction in the territory of the stenotic BA and subsequent ischemic events associated with the stenotic BA. MATERIALS AND METHODS: Sixty patients with symptomatic atherosclerotic BA stenosis ≥70% were enrolled consecutively. HR-MRI of cross-sectional BAs was obtained before and after contrast media injection, and wall enhancement indices were calculated for sections proximal to, at, and distal to the site of maximal luminal narrowing. DWI of the brain was performed to determine the presence of recent infarction. RESULTS: Images from 56 patients were suitable for analysis. Thirty-three patients underwent stent placement for the stenotic BA, and 23 patients underwent conservative medical treatment with antiplatelet agents and risk-factor control. All 23 patients with medical treatment had a 12-month follow-up. Greater wall enhancement was seen in the section proximal to the MLN section in both patients with recent infarction (74 ± 65% versus 44 ± 44%; P = .046) and in patients with subsequent ischemic events (100 ± 57% versus 44 ± 44%; P = .014). CONCLUSIONS: Greater wall enhancement proximal to the MLN site correlates with recent infarction in the territory of the stenotic BA and subsequent ischemic events associated with the stenotic BA. Contrast-enhanced HR-MRI may serve as a noninvasive tool for risk stratification of BA atherosclerosis.
BACKGROUND AND PURPOSE: Contrast-enhanced 3T high-resolution MR imaging can be used to determine the wall enhancement pattern of the basilar artery in symptomatic atherosclerotic stenosis. We used this method to explore the relationship between wall enhancement and both recent infarction in the territory of the stenotic BA and subsequent ischemic events associated with the stenotic BA. MATERIALS AND METHODS: Sixty patients with symptomatic atheroscleroticBA stenosis ≥70% were enrolled consecutively. HR-MRI of cross-sectional BAs was obtained before and after contrast media injection, and wall enhancement indices were calculated for sections proximal to, at, and distal to the site of maximal luminal narrowing. DWI of the brain was performed to determine the presence of recent infarction. RESULTS: Images from 56 patients were suitable for analysis. Thirty-three patients underwent stent placement for the stenotic BA, and 23 patients underwent conservative medical treatment with antiplatelet agents and risk-factor control. All 23 patients with medical treatment had a 12-month follow-up. Greater wall enhancement was seen in the section proximal to the MLN section in both patients with recent infarction (74 ± 65% versus 44 ± 44%; P = .046) and in patients with subsequent ischemic events (100 ± 57% versus 44 ± 44%; P = .014). CONCLUSIONS: Greater wall enhancement proximal to the MLN site correlates with recent infarction in the territory of the stenotic BA and subsequent ischemic events associated with the stenotic BA. Contrast-enhanced HR-MRI may serve as a noninvasive tool for risk stratification of BAatherosclerosis.
Authors: Tobias Saam; Thomas S Hatsukami; Norihide Takaya; Baocheng Chu; Hunter Underhill; William S Kerwin; Jianming Cai; Marina S Ferguson; Chun Yuan Journal: Radiology Date: 2007-07 Impact factor: 11.105
Authors: Jianming Cai; Thomas S Hatsukami; Marina S Ferguson; William S Kerwin; Tobias Saam; Baocheng Chu; Norihide Takaya; Nayak L Polissar; Chun Yuan Journal: Circulation Date: 2005-11-21 Impact factor: 29.690
Authors: M J McCarthy; I M Loftus; M M Thompson; L Jones; N J London; P R Bell; A R Naylor; N P Brindle Journal: J Vasc Surg Date: 1999-08 Impact factor: 4.268
Authors: Lyndon C Box; Dominick J Angiolillo; Nobuaki Suzuki; Lesleigh A Box; Julie Jiang; Luiz Guzman; Martin A Zenni; Theodore A Bass; Marco A Costa Journal: Catheter Cardiovasc Interv Date: 2007-09 Impact factor: 2.692
Authors: C Zhu; X Tian; A J Degnan; Z Shi; X Zhang; L Chen; Z Teng; D Saloner; J Lu; Q Liu Journal: AJNR Am J Neuroradiol Date: 2018-05-24 Impact factor: 3.825
Authors: A G van der Kolk; J J M Zwanenburg; N P Denswil; A Vink; W G M Spliet; M J A P Daemen; F Visser; D W J Klomp; P R Luijten; J Hendrikse Journal: AJNR Am J Neuroradiol Date: 2014-12-04 Impact factor: 3.825
Authors: Petrice M Cogswell; Taylor L Davis; Megan K Strother; Carlos C Faraco; Allison O Scott; Lori C Jordan; Matthew R Fusco; Blaise deB Frederick; Jeroen Hendrikse; Manus J Donahue Journal: J Magn Reson Imaging Date: 2017-01-06 Impact factor: 4.813
Authors: D M Mandell; M Mossa-Basha; Y Qiao; C P Hess; F Hui; C Matouk; M H Johnson; M J A P Daemen; A Vossough; M Edjlali; D Saloner; S A Ansari; B A Wasserman; D J Mikulis Journal: AJNR Am J Neuroradiol Date: 2016-07-28 Impact factor: 3.825
Authors: S Omodaka; H Endo; K Niizuma; M Fujimura; T Inoue; K Sato; S-I Sugiyama; T Tominaga Journal: AJNR Am J Neuroradiol Date: 2016-03-03 Impact factor: 3.825
Authors: Jae W Song; Brianna F Moon; Morgan P Burke; Srikant Kamesh Iyer; Mark A Elliott; Haochang Shou; Steven R Messé; Scott E Kasner; Laurie A Loevner; Mitchell D Schnall; John E Kirsch; Walter R Witschey; Zhaoyang Fan Journal: J Neuroimaging Date: 2020-05-11 Impact factor: 2.486